Clinical Trial Update: Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This notice reports the withdrawal of a Phase 3 clinical trial studying a rimonabant and metformin combination for blood sugar control in adults with Type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rimonabant (rimonabant)
• metformin (metformin)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: WITHDRAWN